NCT00987948View on ClinicalTrials.gov

Maraviroc Intensification and Peripheral Blood Monocyte HIV DNA Levels

PHASE2CompletedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

November 30, 2012

Study Completion Date

August 31, 2013

Conditions

HIV Infections

Interventions

DRUG

maraviroc (Selzentry)

dosage varies with other medications being taken; will follow package insert guidelines

Trial Locations (1)

96816

Hawaii Center for AIDS, Honolulu

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

University of Hawaii

OTHER